A pharmacologist is testing a new Alzheimer’s drug on 300 patients. One-third show significant cognitive improvement, 40% experience mild side effects, and 12% show both improvement and side effects. How many patients showed improvement without side effects?
["Title: Clinical Breakthrough: Alzheimer’s Drug Shows Promising Results in Phase Trial", "In a pivotal Phase trial exploring a potential new treatment for Alzheimer’s disease, a dedicated pharmacologist has gathered compelling data from 300 patients. Preliminary analysis reveals notable cognitive improvements and offers insight into the safety profile of the experimental drug. Understanding the distribution of treatment outcomes is critical for evaluating both efficacy and tolerability.", "### Key Findings from the Trial", "The results show that:\n- One-third (33.3%) of patients showed significant cognitive improvement.\n- 40% experienced mild side effects.\n- 12% reported both measurable cognitive enhancement and mild side effects.", "### How Many Improved Without Side Effects?", "To determine the number of patients who showed cognitive improvement without experiencing side effects, we begin by calculating the relevant groups:", "- Number of patients with improvement:\n ( \frac{1}{3} \ imes 300 = 100 ) patients", "- Number of patients with improvement and side effects:\n ( 12% \ imes 300 = 36 ) patients", "Therefore, the patients who improved without side effects are:\n( 100 - 36 = 64 ) patients", "### Conclusion", "Out of the 300 trial participants, 64 patients experienced significant cognitive benefits from the new Alzheimer’s drug without adverse side effects. These promising results underscore the potential of the treatment, while highlighting the importance of monitoring side effects to optimize patient outcomes.", "As ongoing analysis continues, this data offers valuable insight into balancing efficacy and safety, paving the way for future research and possible FDA review. The pharmacologist and research team remain hopeful that this therapy may one day transform Alzheimer’s care.", "---", "Keywords: Alzheimer’s drug trial, cognitive improvement in Alzheimer’s, Phase 3 Alzheimer’s study, pharmacology data, Alzheimer’s cognitive test results, Alzheimer’s side effects trial\nMeta Description: Celebrating early breakthroughs in Alzheimer’s treatment — a 300-patient trial shows 64 patients improved without side effects. Learn key results from the latest pharmacology study."]
